APOC3 and cardiovascular disorder: Finally, within the framework of VHS, in a cohort of 1,020 of patients with cardiovascular disease, subjects with high Apo CIII concentrations had an about three-fold increased risk to experience venous thromboembolic events within a long-term period of 12 years as compared with those with low Apo CIII levels (25).